Cytokinetics (CYTK) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Cytokinetics (CYTK) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Cytokinetics | 9.60 Bn | 8.44 Bn | 25.89 Mn | 104.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.40 Mn |
| Mar 31, 2026 | 104.90 Mn |
| Dec 31, 2025 | 91.72 Mn |
| Sep 30, 2025 | 69.46 Mn |
| Jun 30, 2025 | 65.72 Mn |
| Mar 31, 2025 | 57.37 Mn |
| Dec 31, 2024 | 62.34 Mn |
| Sep 30, 2024 | 56.65 Mn |
| Jun 30, 2024 | 50.82 Mn |
| Mar 31, 2024 | 45.50 Mn |
| Dec 31, 2023 | 44.11 Mn |
| Sep 30, 2023 | 40.11 Mn |
| Jun 30, 2023 | 39.72 Mn |
| Mar 31, 2023 | 49.67 Mn |
| Dec 31, 2022 | 53.97 Mn |
| Sep 30, 2022 | 48.22 Mn |
| Jun 30, 2022 | 42.72 Mn |
| Mar 31, 2022 | 33.07 Mn |
| Dec 31, 2021 | 33.81 Mn |
| Sep 30, 2021 | 26.20 Mn |